Ashley Gallagher, Associate Editor

Setmelanotide is indicated to reduce excess body weight and maintain weight reduction long-term for patients with syndromic or monogenic obesity due to Bardet-Biedl syndrome.

The rare genetic disease is a severe hypertriglyceridemia that can lead to potentially life-threatening acute pancreatitis.

Previously, the evidence to support the prediction with lactate-to-albumin ratio has been unclear.

The tool is designed to address the nocebo effect, which was a concern of prescribers and other health care professionals.

The study authors add that the validation improved the risk score in additional community-acquired pneumonia cohorts, and clinical studies would assess the broad clinical applicability.

Pharmacists play an essential role in educating patients about various health-related topics, including type 2 diabetes and nutrition.

The full results will be published in a peer-reviewed journal and presented at a medical meeting next year as the full results are evaluated.

The 23-valent pneumococcal polysaccharide vaccine (PPSV23, Pneumovax 23; Merck Sharp & Dohme Corp) demonstrates effective reductions in the risk of hospitalizations.

Investigators say basic immunodeficiency screening should be completed in full for this patient population.

The pharmacist’s role includes determining if there are any medications that are contributing to magnesium deficiency for patients with diabetes who are at an increased risk.

Investigators presented additional data from a clinical trial at the American College of Rheumatology Convergence, demonstrating similar safety for postmenopausal women with osteoporosis.

The Act is set to end at the end of 2024, which will affect pharmacists’ abilities to administer COVID-19 tests, vaccines, and treatment that are distributed by the federal government.

The biosimilar is approved for the treatment of Crohn disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis.

The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.

However, the monthly expenditure was not significantly associated with the financial incentives.

Investigators also found that vaccination for those aged 27 to 45 produces a higher number needed to vaccinate.

The disappearance could impact updates for surveillance strategies and vaccine development.

Children with obesity, asthma, and gastrointestinal disease had longer durations of stays compared with children without comorbidities.

Familial chylomicronemia syndrome (FCS) currently has no FDA-approved treatment and is associated with an increased risk of acute pancreatitis.

There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.

Investigators also established a negative association with higher vitamin C intake and diabetes prevalence.

Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.

Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.

This marks the first and only therapy to receive this designation for Sjögren disease, which currently has no approved treatment.

Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.

The disorder presents as severe lung disease, with lung transplantation as the only current therapeutic option for long-term survival.

The label includes postmarking reports showing rare instances of pulmonary aspiration for patients undergoing procedures that require general anesthesia or deep sedation.

Eladocagene exuparvovec-tneq is the first FDA-approved gene therapy for individuals with aromatic L-amino acid decarboxylase deficiency.

In the analysis, 34.7% of commercially insured patients with chronic obstructive pulmonary disease or asthma received an influenza vaccination.

Despite their proven abilities, organizations such as the American Medical Association still oppose so-called “scope creep.”